Subsequent squamous-and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: Cumulative incidence and risk factors

Transplantation

Volumn 89, Issue 10, 2010, Pages 1231-1238

  Wisgerhof, Hermina C ^a   Edelbroek, Jeroen R J ^a   De Fijter, Johan W ^a   Haasnoot, Geert W ^a   Claas, Frans H J ^a   Willemze, Rein ^a   Bavinck, Jan N Bouwes ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Basal cell carcinoma; Incidence; Risk factors; Skin cancer; Squamous cell carcinoma; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; AGE DISTRIBUTION; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

AZATHIOPRINE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; NEOPLASM RECURRENCE, LOCAL; PREDNISONE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; TIME FACTORS;

EID: 77952888852     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181d84cdc     Document Type: Article

References (31)

1. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221.
2. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia A follow-up study. Transplantation 1996; 61: 715.
3. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49: 506.
4. Jensen P, Moller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000; 42: 307.
5. Lindelof B, Sigurgeirsson B, Gabel H, et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513.
6. Moloney FJ, Comber H, O'Lorcain P, et al.Apopulation-based study of skin cancer incidence and prevalencein renal transplant recipients. Br J Dermatol 2006; 154: 498.
7. Naldi L, Fortina AB, Lovati S, et al. Riskof nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479.
8. Fuente MJ, Sabat M, Roca J, et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149: 1221.
9. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574.
10. Wisgerhof HC, van der Boog PJ, de Fijter JW, et al. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients. J Invest Derma-tol 2009; 129: 2886.
11. Mackenzie KA, Wells JE, Lynn KL, et al. First and subsequent nonmela-noma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients. Nephrol Dial Transplant 2010; 25: 300.
12. Euvrard S, Kanitakis J, Decullier E, et al. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma. Transplantation 2006; 81: 1093.
13. Liddington M, Richardson AJ, Higgins RM, et al. Skin cancer in renal transplant recipients. Br J Surg 1989; 76: 1002.
14. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: A critical review of the literature and meta-analysis. Arch Dermatol 2000; 136: 1524.
15. Pandeya N, Purdie DM, Green A, et al. Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial. Am J Epidemiol 2005; 161: 748.
16. Richmond-Sinclair NM, Pandeya N, Ware RS, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009; 129: 323.
17. Boyle J, MacKie RM, Briggs JD, et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 702.
18. Caforio AL, Fortina AB, Piaserico S, et al. Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppres-sive therapy. Circulation 2000; 102: III222.
19. Jensen P, Hansen S, Moller B, et al. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone? Transplant Proc 1999; 31: 1120.
20. Lindelof B, Gabel H. [Great risk of skin cancer in patients with transplanted organs. Sun is the most dangerous enemy]. Lakartidningen 2000; 97: 4822.
21. Ramsay HM, Fryer AA, Hawley CM, et al. Factors associated with non-melanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49: 397.
22. Rubin AI, Chen EH, RatnerD. Basal-cell carcinoma. N EnglJMed2005; 353: 2262.
23. Corona R, Dogliotti E, D'Errico M, et al. Risk factors for basal cell carcinoma in a Mediterranean population: Role of recreational sun exposure early in life. Arch Dermatol 2001; 137: 1162.
24. Espana A, Redondo P, Fernandez AL, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32: 458.
25. Fortina AB, Piaserico S,Caforio AL,etal. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140: 1079.
26. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features ofskin cancer inorgan transplant recipients:Aretrospective case-control series. J Am Acad Dermatol 2006; 54: 290.
27. Kanitakis J, Alhaj-Ibrahim L, Euvrard S, et al. Basal cell carcinomas developing in solid organ transplant recipients: Clinicopathologic study of 176 cases. Arch Dermatol 2003; 139: 1133.
28. Kricker A, Armstrong BK, English DR, et al. Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995; 60: 489.
29. Ingvar A, Smedby KE, Lindelof B, et al. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma. Nephrol Dial Transplant (in press).
30. O'Donovan P, Perrett CM, Zhang X, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871.
31. Ramsay HM, Fryer AA, Reece S, et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167.